Role of microtubule actin crosslinking factor 1 (MACF1) in bipolar disorder pathophysiology and potential in lithium therapeutic mechanism

Transl Psychiatry. 2023 Jun 23;13(1):221. doi: 10.1038/s41398-023-02483-6.

Abstract

Bipolar affective disorder (BPAD) are life-long disorders that account for significant morbidity in afflicted patients. The etiology of BPAD is complex, combining genetic and environmental factors to increase the risk of disease. Genetic studies have pointed toward cytoskeletal dysfunction as a potential molecular mechanism through which BPAD may arise and have implicated proteins that regulate the cytoskeleton as risk factors. Microtubule actin crosslinking factor 1 (MACF1) is a giant cytoskeletal crosslinking protein that can coordinate the different aspects of the mammalian cytoskeleton with a wide variety of actions. In this review, we seek to highlight the functions of MACF1 in the nervous system and the molecular mechanisms leading to BPAD pathogenesis. We also offer a brief perspective on MACF1 and the role it may be playing in lithium's mechanism of action in treating BPAD.

Publication types

  • Review

MeSH terms

  • Actins / metabolism
  • Bipolar Disorder* / drug therapy
  • Bipolar Disorder* / metabolism
  • Cytoskeleton / metabolism
  • Humans
  • Lithium / pharmacology
  • Lithium / therapeutic use
  • Microfilament Proteins* / metabolism
  • Microfilament Proteins* / therapeutic use
  • Microtubules / metabolism

Substances

  • Actins
  • Lithium
  • MACF1 protein, human
  • Microfilament Proteins